Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice.
Saved in:
| Title: | Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice. |
|---|---|
| Authors: | Jeong JH; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Kim SO; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Min SC; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Kim EG; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Song MS; Department of Microbiology, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea., Shin EY; Department of Biochemistry, Chungbuk National University College of Medicine and Medical Research Center, Chungbuk National University Hospital, Cheongju, Republic of Korea. |
| Source: | FEBS open bio [FEBS Open Bio] 2025 Mar; Vol. 15 (3), pp. 427-435. Date of Electronic Publication: 2025 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101580716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5463 (Electronic) Linking ISSN: 22115463 NLM ISO Abbreviation: FEBS Open Bio Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2211-5463 |
|---|---|
| DOI: | 10.1002/2211-5463.70002 |
